News about Cancer

Ditte Boilesen

Ph.D., Faculty of Health and Medical Sciences, University of Copenhagen

Niels Behrendt receives the NNF Distinguished Innovator Grant

Niels Behrendt, group leader at the Finsen Laboratory, Rigshospitalet/BRIC receives the NNF Distinguished Innovator grant for a project focused on creating test ADC therapeutics.

New project will design 3D microfluidic chips for cancer therapy

Associate Professor Anan Yaghmur has received 2.9 mill DKK from Novo Nordisk Foundation for the project “MICNANO: MICrofluidic synthesis and online characterization of cubosomal and hexosomal NANOcarriers for colorectal…

Now we understand better how cell division works. That puts us a step closer to devising more effective cancer therapies

How does a cell know when to divide? Researchers have found the answer, and it may prove significant to future cancer therapy.

New gene technology is able to predict the effect of treatment on the individual breast cancer patient

How do you know whether breast cancer treatment will be able to cure the individual patient? New gene technology can tell us, and it may prove vital to patients.

Major discovery about mammalian brains surprises researchers

In a new breakthrough to understand more about the mammalian brain, University of Copenhagen researchers have made an incredible discovery. Namely, a vital enzyme that enables brain signals is switching on and off at…

UCPH research fights life-threatening infections in lymphoma patients

Skin lymphoma can lead to severe and even deadly infections. New research from the University of Copenhagen paves the way for prevention.

How cancer cells hide from chemotherapy

The Jensen Group, published in Gastroenterology, shows how blocking a cancer cell's ability to divide could improve treatment for people with colorectal cancer.

Translational AML trial improves clinical outcome and identifies novel drugs for future treatment

The LD-VenEx trial exemplifies the vast potential of clinical trials integrating translational research programs, says research group leader Kim Theilgaard-Mönch. In a large investigator-initiated trial, clinicians form…

Three proteins join forces to spread cancer. Now scientists may destroy them

With cryo-electron microscopy, it is possible to examine proteins more than a 1,000 times smaller than the width of a human hair. Now research using the technology may help develop treatment for some of the deadliest…

Three proteins join forces to spread cancer. Now scientists may destroy them

With cryo-electron microscopy, it is possible to examine proteins more than a 1,000 times smaller than the width of a human hair. Now research using the technology may help develop treatment for some of the deadliest…

Dormant tumour cells use a differentiated cloak to hide from treatments

Researchers from the Jensen Group have analysed a great number of colon tumours aiming to understand how some tumour cells avoid dying upon treatment with chemotherapies. Findings published in Gastroenterology.

Bogdan Cristinoi

Ph.D., Faculty of Health and Medical Sciences, University of Copenhagen

Rationale for combination therapy in acute myeloid leukemia

Acute myeloid leukemia (AML) is a highly heterogeneous disease for which there is an unmet need for improved targeted therapies. In a new study, the Olsen Group and collaborators use phosphoproteomics to devise rational…

The immune system can help us diagnose cancer

How do you detect a dangerous cancer if you do not know exactly what to look for or where? New research into biliary tract cancer conducted at the University of Copenhagen can pave the way for early detection of the…

Cancer increases the risk of developing diabetes

Cancer patients are at a greater risk for developing diabetes, according to a new study by the Steno Diabetes Center Copenhagen, Rigshospitalet, and the University of Copenhagen. The study also concludes that cancer…

Novel insight into cell killing by anticancer agents

PP2A is a known tumor suppressor and given that its function is suppressed in many cancers, there is an interest in developing compounds that can reactivate PP2A for cancer treatment.

Cancer vulnerabilities could get exposed by ‘game changing’ method

Research from University of Copenhagen shows that a new method called “Deep Visual Proteomics” may be able to help doctors get closer to an answer and expose cancer tumor’s vulnerabilities.

Octopus-like tentacles help cancer cells invade the body

With the help of the worlds best tweezers a team of researchers from the University of Copenhagen has shed new light on a fundamental mechanism in all living cells that helps them explore their surroundings and even…

Octopus-like tentacles help cancer cells invade the body

With the help of the worlds best tweezers a team of researchers from the University of Copenhagen has shed new light on a fundamental mechanism in all living cells that helps them explore their surroundings and even…

Nicolai Tue Sand

Ph.D., Faculty of Health and Medical Sciences, University of Copenhagen

New discovery may pave the way for more targeted treatment of cancer patients

Women with certain mutations in BRCA2 have an increased risk of breast and ovarian cancer. The new study can pave the way for more targeted treatment of a group of cancer patients with mutations in BRCA2.

Using artificial intelligence to fingerprint suspicious proteins

An artificial intelligence tool created by researchers at the University of Copenhagen can quickly and accurately identify suspicious or particularly 'talented' proteins in our bodies based upon their movements alone.…

Using artificial intelligence to fingerprint suspicious proteins

An artificial intelligence tool created by researchers at the University of Copenhagen can quickly and accurately identify suspicious or particularly 'talented' proteins in our bodies based upon their movements alone.…